Back
Cartesian Therapeutics Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
70
RNAC
Cartesian Therapeutics
Last Price:
16.94
Seasonality Move:
10.73%
Sell
46
ANIP
ANI Pharmaceuticals
Last Price:
61.01
Seasonality Move:
5.08%
Buy
70
Cartesian Therapeutics (RNAC)
is a Buy
Is Cartesian Therapeutics a Buy, Sell or Hold?
- The current Cartesian Therapeutics [RNAC] share price is $19.78. The Score for RNAC is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- RNAC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.85. The Score for ANIP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ANIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNAC Stock Price Chart
What is Cartesian Therapeutics's stock price today?
-
The Cartesian Therapeutics share price today is $19.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing slight selling pressure.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNAC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 46.9 | Sell |
Chaikin Money Flow: | -46344 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.17 - 22.57) | Sell |
Bollinger Bands (100): | (14.27 - 21.53) | Buy |
ANIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 60.98 | Buy |
Chaikin Money Flow: | 213168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.73 - 59.99) | Buy |
Bollinger Bands (100): | (57.71 - 62.95) | Buy |
RNAC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.04 | Sell |
20-day SMA: | 21.13 | Sell |
50-day SMA: | 18.79 | Buy |
200-day SMA: | 20.16 | Sell |
8-day EMA: | 20.4 | Sell |
20-day EMA: | 20.55 | Sell |
50-day EMA: | 19.57 | Buy |
200-day EMA: | 21.28 | Sell |
ANIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.64 | Buy |
20-day SMA: | 58.88 | Buy |
50-day SMA: | 58.7 | Buy |
200-day SMA: | 62.08 | Sell |
8-day EMA: | 59.48 | Buy |
20-day EMA: | 58.83 | Buy |
50-day EMA: | 59.09 | Buy |
200-day EMA: | 59.9 | Buy |
Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.49 per share.
Cartesian Therapeutics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ANI Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |